| Literature DB >> 24455490 |
Abstract
Vibrio parahaemolyticus elicits gastroenteritis by deploying Type III Secretion Systems (TTSS) to deliver effector proteins into epithelial cells of the human intestinal tract. The bacteria must adhere to the human cells to allow colonization and operation of the TTSS translocation apparatus bridging the bacterium and the host cell. This article first reviews recent advances in identifying the molecules responsible for intercellular adherence. V. parahaemolyticus possesses two TTSS, each of which delivers an exclusive set of effectors and mediates unique effects on the host cell. TTSS effectors primarily target and alter the activation status of host cell signaling proteins, thereby bringing about changes in the regulation of cellular behavior. TTSS1 is responsible for the cytotoxicity of V. parahaemolyticus, while TTSS2 is necessary for the enterotoxicity of the pathogen. Recent publications have elucidated the function of several TTSS effectors and their importance in the virulence of the bacterium. This review will explore the ability of the TTSS to manipulate activities of human intestinal cells and how this modification of cell function favors bacterial colonization and persistence of V. parahaemolyticus in the host.Entities:
Keywords: MshA; TTSS; Vibrio parahaemolyticus; effector; intestinal cells
Mesh:
Substances:
Year: 2014 PMID: 24455490 PMCID: PMC3887276 DOI: 10.3389/fcimb.2013.00114
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Figure 1TTSS-associated morphological alterations in intestinal cells require a functional MSHA pilus. (A,B) Giemsa stained co-cutures of wild type (A) or ΔmshAl (B) V. parahaemolyticus and Caco-2 following 1 h of incubation and removel of non-adherent bacteria. (C,D) Phalloidin- Alexa 568/Hoechst 33342 stained Caco-2 visualized by epifluorescence microscopy following 2.5 h of infection with wild-type (C) or ΔmshAl (D) V. parahaemolyticus. Scale bars represent 50 μm.
Characterized .
| VopC | Activation of Rac and Cdc42 by deamidation | Invasion of non-phagocytic cells | – | VopC (48) | VopC (50) | |
| VopT | ADP-ribosylation of Ras | Cytotoxicity | – | – | – | |
| VopZ | Inhibition of TAK1, and downstream MAPK and NF-κB | Enterotoxicity, colonization | VopZ (50) | VopZ (25) | – | |
| VopA/VopP | Inhibition of MAPK by acetylation of MKK | Growth inhibition in yeast | – | VopP (63) | VopP (64) | |
| VopV | Actin binding and bundling | Enterotoxicity by fluid accumulation and blunting of villi | VopM (55) | VopM (38) | – | |
| VopL | Actin nucleation | Formation of stress filaments, altered cell shape | VopF (62) | VopN (38) | VopL (36) |
% amino acid identity to the corresponding V. parahaemolyticus RIMD2201633 TTSS2 effector.
Designates less than 20% amino acid identity to any protein in the strain.
Figure 2Activity of the .
Characterized .
| VopQ/VepA | Binds V-ATPase and forms pores in lysosomal membranes | Lysosomal deacidification, autophagy, cell lysis, activation of MAPK, secretion of IL-8 | |
| VopS | Inhibition of Rho GTPases by AMPylation | Rounding of host cells, invasion of phagocytes | |
| VPA0450 | Phosphatidylinositol phosphatase | Membrane blebbing and destabilization in HeLa cells |